Congenital Heart Defects: Prostaglandins and Prostaglandin InhibitorsCurrent as of: October 5, 2017 |
|
Congenital Heart Defects: Prostaglandins and Prostaglandin InhibitorsTopic OverviewNormally, a blood vessel needed only for fetal blood circulation (called the ductus arteriosus) closes off at birth. As the fetus develops, this blood vessel is kept open by a substance in the fetus's body called prostaglandin. At birth, prostaglandin decreases and the blood vessel closes. In some premature infants, this blood vessel does not close. This is a condition called a patent (open) ductus arteriosus . These infants are given a prostaglandin inhibitor. It's a medicine to help the blood vessel close. When an infant has certain other congenital heart defects , a medicine that is a form of prostaglandin is often given by vein to keep the ductus arteriosus open. Keeping this blood vessel open allows the blood to keep moving until the defect can be fixed to allow normal blood flow. This may require surgery or another procedure. Related InformationCredits
ByHealthwise Staff Current as ofOctober 5, 2017
Current as of: October 5, 2017 |
Search the
Healthwise Knowledgebase Topic ContentsThis information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content. To learn more about Healthwise, visit Healthwise.org. © 1995-2018 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. |